Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy

Direct Acting Antivirals (DAAs) represent a large improvement in the treatment of chronic hepatitis C, resulting in

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PeerJ (San Francisco, CA) CA), 2021-09, Vol.9, p.e12051-e12051, Article e12051
Hauptverfasser:	Melendez-Mena, Daniel, Mendoza-Torres, Miguel Angel, Sedeño-Monge, Virginia, García Y García, Víctor Hugo, Rivera-García, Elain, Sánchez-Reza, Laura, Baxin Domínguez, María Del Carmen, Guzmán-Flores, Belinda, Martinez-Laguna, Ygnacio, Coronel Espinoza, José Manuel, Galindo-Santiago, Iván, Flores-Alonso, Juan Carlos, Vallejo-Ruiz, Verónica, Cortes-Hernandez, Paulina, Reyes-Leyva, Julio, Sosa-Jurado, Francisca, Santos-López, Gerardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents APRI index Biological response modifiers Care and treatment Child-Pugh-Score Direct acting antivirals Drugs and Devices FIB-4 Fibrosis Gastroenterology and Hepatology Genetic aspects Genotype & phenotype Genotypes Hepatitis C Hepatitis C virus Infectious Diseases Interferon Laboratories Liver Liver cirrhosis Patients Protease inhibitors Public health Ribavirin Ritonavir RNA polymerase Sustained viral response Transaminase Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Direct Acting Antivirals (DAAs) represent a large improvement in the treatment of chronic hepatitis C, resulting in
ISSN:	2167-8359 2167-8359
DOI:	10.7717/peerj.12051